ENVA

SEC source: 0000899243-22-006490 · doc4.xml · nonDerivative · entry 2

Chartier Kirk · CIK 0001483333 · Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 145,815

F1 · shares: This transaction represents the withholding by Enova International, Inc. ("Issuer") of Issuer's shares to pay taxes in connections with the vesting of restricted stock units on the Transaction Date. The timing and amount of the transaction were determined by the terms of the applicable restricted stock and were not within the control of the Reporting Person.

F2 · balance_after: Includes timed-based restricted stock units previously granted to the Reporting Person.

SEC source: 0000899243-22-006486 · doc4.xml · nonDerivative · entry 2

Fisher David · CIK 0001315224 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 470,334

F1 · shares: This transaction represents the withholding by Enova International, Inc. ("Issuer") of Issuer's shares to pay taxes in connections with the vesting of restricted stock units on the Transaction Date. The timing and amount of the transaction were determined by the terms of the applicable restricted stock and were not within the control of the Reporting Person.

F2 · balance_after: Includes timed-based restricted stock units previously granted to the Reporting Person.

SEC source: 0000899243-22-006494 · doc4.xml · nonDerivative · entry 2

Lee James Joseph · CIK 0001834433 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,410

F1 · shares: This transaction represents the withholding by Enova International, Inc. ("Issuer") of Issuer's shares to pay taxes in connections with the vesting of restricted stock units on the Transaction Date. The timing and amount of the transaction were determined by the terms of the applicable restricted stock and were not within the control of the Reporting Person.

F2 · balance_after: Includes timed-based restricted stock units previously granted to the Reporting Person.

SEC source: 0000899243-22-006492 · doc4.xml · nonDerivative · entry 2

Cunningham Steven E · CIK 0001575452 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 209,680

F1 · shares: This transaction represents the withholding by Enova International, Inc. ("Issuer") of Issuer's shares to pay taxes in connections with the vesting of restricted stock units on the Transaction Date. The timing and amount of the transaction were determined by the terms of the applicable restricted stock and were not within the control of the Reporting Person.

F2 · balance_after: Includes timed-based restricted stock units previously granted to the Reporting Person.

SEC source: 0000899243-22-006491 · doc4.xml · nonDerivative · entry 2

Rahilly Sean · CIK 0001621195 · General Counsel and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,861

F1 · shares: This transaction represents the withholding by Enova International, Inc. ("Issuer") of Issuer's shares to pay taxes in connections with the vesting of restricted stock units on the Transaction Date. The timing and amount of the transaction were determined by the terms of the applicable restricted stock and were not within the control of the Reporting Person.

F2 · balance_after: Includes timed-based restricted stock units previously granted to the Reporting Person.

SEC source: 0000899243-22-009539 · doc4a.xml · nonDerivative · entry 2

Lee James Joseph · CIK 0001834433 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,406

F1 · shares: This transaction represents the withholding by Enova International, Inc. ("Issuer") of Issuer's shares to pay taxes in connections with the vesting of restricted stock units on the Transaction Date. The timing and amount of the transaction were determined by the terms of the applicable restricted stock and were not within the control of the Reporting Person.

F2 · balance_after: Includes timed-based restricted stock units previously granted to the Reporting Person.

F3 · balance_after: The original Form 4, filed February 15, 2022, is being amended by this Form 4 Amendment solely to correct an administrative error, which misreported the amount of securities beneficially owned following the transactions dated February 11, 2022 and February 12, 2022 as 17,735 and 17,410, respectively, when the correct amounts should have 17,731 and 17,406 shares, respectively.

SEC source: 0000899243-22-006490 · doc4.xml · nonDerivative · entry 1

Chartier Kirk · CIK 0001483333 · Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 147,970

F1 · shares: This transaction represents the withholding by Enova International, Inc. ("Issuer") of Issuer's shares to pay taxes in connections with the vesting of restricted stock units on the Transaction Date. The timing and amount of the transaction were determined by the terms of the applicable restricted stock and were not within the control of the Reporting Person.

F2 · balance_after: Includes timed-based restricted stock units previously granted to the Reporting Person.

SEC source: 0000899243-22-006486 · doc4.xml · nonDerivative · entry 1

Fisher David · CIK 0001315224 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 481,698

F1 · shares: This transaction represents the withholding by Enova International, Inc. ("Issuer") of Issuer's shares to pay taxes in connections with the vesting of restricted stock units on the Transaction Date. The timing and amount of the transaction were determined by the terms of the applicable restricted stock and were not within the control of the Reporting Person.

F2 · balance_after: Includes timed-based restricted stock units previously granted to the Reporting Person.

SEC source: 0000899243-22-006494 · doc4.xml · nonDerivative · entry 1

Lee James Joseph · CIK 0001834433 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,735

F1 · shares: This transaction represents the withholding by Enova International, Inc. ("Issuer") of Issuer's shares to pay taxes in connections with the vesting of restricted stock units on the Transaction Date. The timing and amount of the transaction were determined by the terms of the applicable restricted stock and were not within the control of the Reporting Person.

F2 · balance_after: Includes timed-based restricted stock units previously granted to the Reporting Person.

SEC source: 0000899243-22-006492 · doc4.xml · nonDerivative · entry 1

Cunningham Steven E · CIK 0001575452 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 212,859

F1 · shares: This transaction represents the withholding by Enova International, Inc. ("Issuer") of Issuer's shares to pay taxes in connections with the vesting of restricted stock units on the Transaction Date. The timing and amount of the transaction were determined by the terms of the applicable restricted stock and were not within the control of the Reporting Person.

F2 · balance_after: Includes timed-based restricted stock units previously granted to the Reporting Person.

SEC source: 0000899243-22-006491 · doc4.xml · nonDerivative · entry 1

Rahilly Sean · CIK 0001621195 · General Counsel and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,644

F1 · shares: This transaction represents the withholding by Enova International, Inc. ("Issuer") of Issuer's shares to pay taxes in connections with the vesting of restricted stock units on the Transaction Date. The timing and amount of the transaction were determined by the terms of the applicable restricted stock and were not within the control of the Reporting Person.

F2 · balance_after: Includes timed-based restricted stock units previously granted to the Reporting Person.

SEC source: 0000899243-22-009539 · doc4a.xml · nonDerivative · entry 1

Lee James Joseph · CIK 0001834433 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,731

F1 · shares: This transaction represents the withholding by Enova International, Inc. ("Issuer") of Issuer's shares to pay taxes in connections with the vesting of restricted stock units on the Transaction Date. The timing and amount of the transaction were determined by the terms of the applicable restricted stock and were not within the control of the Reporting Person.

F2 · balance_after: Includes timed-based restricted stock units previously granted to the Reporting Person.

F3 · balance_after: The original Form 4, filed February 15, 2022, is being amended by this Form 4 Amendment solely to correct an administrative error, which misreported the amount of securities beneficially owned following the transactions dated February 11, 2022 and February 12, 2022 as 17,735 and 17,410, respectively, when the correct amounts should have 17,731 and 17,406 shares, respectively.

SEC source: 0000899243-22-005958 · doc4.xml · derivative · entry 4

Fisher David · CIK 0001315224 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,118,850

Underlying: Common stock, par value $0.00001 per share · 68,022 shares

Expires 2022-03-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.

F4 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.

F6 · derivative.exercise_price: The price reported in Column 2 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.00 to $46.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F5 · derivative.exercise_date: The options vested in substantially equal one-third increments on each of the following dates as long as grantee served as an employee of Issuer or an affiliate thereof through the applicable vesting date March 20, 2015, March 20, 2016 and March 20, 2017.

SEC source: 0000899243-22-007754 · doc4a.xml · derivative · entry 2

Fisher David · CIK 0001315224 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,123,206

Underlying: Common stock, par value $0.00001 per share · 68,022 shares

Expires 2022-03-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.

F2 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.

F5 · derivative.exercise_price: The price reported in Column 2 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.75 to $39.93, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F3 · derivative.exercise_date: The options vested in substantially equal one-third increments on each of the following dates as long as grantee served as an employee of Issuer or an affiliate thereof through the applicable vesting date March 20, 2015, March 20, 2016 and March 20, 2017.

F6 · balance_after: The original Form 4, filed February 11, 2022, is being amended by this Form 4 Amendment solely to correct an administrative error, which misreported the total number of derivative securities beneficially owned following the transaction as 1,118, 850 when the correct amount is 1,123,206

SEC source: 0000899243-22-005958 · doc4.xml · derivative · entry 3

Fisher David · CIK 0001315224 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,186,872

Underlying: Common stock, par value $0.00001 per share · 100 shares

Expires 2022-03-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.

F4 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.

F5 · derivative.exercise_date: The options vested in substantially equal one-third increments on each of the following dates as long as grantee served as an employee of Issuer or an affiliate thereof through the applicable vesting date March 20, 2015, March 20, 2016 and March 20, 2017.

SEC source: 0000899243-22-005958 · doc4.xml · nonDerivative · entry 2

Fisher David · CIK 0001315224 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 494,323

F1 · shares: This transaction represents the withholding by Enova International, Inc. ("Issuer") of Issuer's shares to pay taxes in connections with the vesting of restricted stock units on the Transaction Date. The timing and amount of the transaction were determined by the terms of the applicable restricted stock and were not within the control of the Reporting Person.

F2 · balance_after: Includes timed-based restricted stock units previously granted to the Reporting Person.

SEC source: 0000899243-22-005958 · doc4.xml · nonDerivative · entry 1

Fisher David · CIK 0001315224 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 506,986

F1 · shares: This transaction represents the withholding by Enova International, Inc. ("Issuer") of Issuer's shares to pay taxes in connections with the vesting of restricted stock units on the Transaction Date. The timing and amount of the transaction were determined by the terms of the applicable restricted stock and were not within the control of the Reporting Person.

F2 · balance_after: Includes timed-based restricted stock units previously granted to the Reporting Person.

SEC source: 0000899243-22-005946 · doc4.xml · nonDerivative · entry 2

Cunningham Steven E · CIK 0001575452 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 215,111

F1 · shares: This transaction represents the withholding by Enova International, Inc. ("Issuer") of Issuer's shares to pay taxes in connections with the vesting of restricted stock units on the Transaction Date. The timing and amount of the transaction were determined by the terms of the applicable restricted stock and were not within the control of the Reporting Person.

F2 · balance_after: Includes timed-based restricted stock units previously granted to the Reporting Person.

SEC source: 0000899243-22-005946 · doc4.xml · nonDerivative · entry 1

Cunningham Steven E · CIK 0001575452 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 217,298

F1 · shares: This transaction represents the withholding by Enova International, Inc. ("Issuer") of Issuer's shares to pay taxes in connections with the vesting of restricted stock units on the Transaction Date. The timing and amount of the transaction were determined by the terms of the applicable restricted stock and were not within the control of the Reporting Person.

F2 · balance_after: Includes timed-based restricted stock units previously granted to the Reporting Person.

SEC source: 0000899243-22-005951 · doc4.xml · nonDerivative · entry 1

Lee James Joseph · CIK 0001834433 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,090

F1 · shares: This transaction represents the withholding by Enova International, Inc. ("Issuer") of Issuer's shares to pay taxes in connections with the vesting of restricted stock units on the Transaction Date. The timing and amount of the transaction were determined by the terms of the applicable restricted stock and were not within the control of the Reporting Person.

F2 · balance_after: Includes timed-based restricted stock units previously granted to the Reporting Person.

SEC source: 0000899243-22-005925 · doc4.xml · nonDerivative · entry 2

Rahilly Sean · CIK 0001621195 · General Counsel and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 81,552

F1 · shares: This transaction represents the withholding by Enova International, Inc. ("Issuer") of Issuer's shares to pay taxes in connections with the vesting of restricted stock units on the Transaction Date. The timing and amount of the transaction were determined by the terms of the applicable restricted stock and were not within the control of the Reporting Person.

F2 · balance_after: Includes timed-based restricted stock units previously granted to the Reporting Person.

SEC source: 0000899243-22-005925 · doc4.xml · nonDerivative · entry 1

Rahilly Sean · CIK 0001621195 · General Counsel and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 82,437

F1 · shares: This transaction represents the withholding by Enova International, Inc. ("Issuer") of Issuer's shares to pay taxes in connections with the vesting of restricted stock units on the Transaction Date. The timing and amount of the transaction were determined by the terms of the applicable restricted stock and were not within the control of the Reporting Person.

F2 · balance_after: Includes timed-based restricted stock units previously granted to the Reporting Person.

SEC source: 0000899243-22-007754 · doc4a.xml · derivative · entry 1

Fisher David · CIK 0001315224 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,191,228

Underlying: Common stock, par value $0.00001 per share · 100 shares

Expires 2022-03-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.

F2 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.

F3 · derivative.exercise_date: The options vested in substantially equal one-third increments on each of the following dates as long as grantee served as an employee of Issuer or an affiliate thereof through the applicable vesting date March 20, 2015, March 20, 2016 and March 20, 2017.

F4 · balance_after: The original Form 4, filed February 11, 2022, is being amended by this Form 4 Amendment solely to correct an administrative error, which misreported the total number of derivative securities beneficially owned following the transaction as 1,186, 872 when the correct amount is 1,191,228.

SEC source: 0000899243-22-009578 · doc4a.xml · nonDerivative · entry 1

Lee James Joseph · CIK 0001834433 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,086

F1 · shares: This transaction represents the withholding by Enova International, Inc. ("Issuer") of Issuer's shares to pay taxes in connections with the vesting of restricted stock units on the Transaction Date. The timing and amount of the transaction were determined by the terms of the applicable restricted stock and were not within the control of the Reporting Person.

F2 · balance_after: Includes timed-based restricted stock units previously granted to the Reporting Person.

F3 · balance_after: The original Form 4, filed February 11, 2022, is being amended by this Form 4 Amendment solely to correct an administrative error, which misreported the amount of securities beneficially owned following the transaction dated February 9, 2022 as 18,090 when the correct amounts should have 18,086.

SEC source: 0000899243-22-005672 · doc4.xml · derivative · entry 2

Chartier Kirk · CIK 0001483333 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 233,667

Underlying: Common stock, par value $0.00001 per share · 7,205 shares

Expires 2029-02-08

F2 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.

F3 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.

F4 · derivative.exercise_date: The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: February 8, 2023, February 8, 2024 and February 8, 2025.

SEC source: 0000899243-22-005672 · doc4.xml · nonDerivative · entry 1

Chartier Kirk · CIK 0001483333 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 153,590

F1 · shares: This transaction reflects a grant of restricted stock units that shall vest in substantially equal one-fourth increments on each of the following dates as long as grantee serves as an employee of the Issuer or an affiliate thereof through the applicable vesting date: February 8, 2023, February 8, 2024, February 8, 2025 and February 8, 2026.

SEC source: 0000899243-22-005690 · doc4.xml · derivative · entry 2

Fisher David · CIK 0001315224 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,186,972

Underlying: Common stock, par value $0.00001 per share · 34,991 shares

Expires 2029-02-08

F2 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.

F3 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.

F4 · derivative.exercise_date: The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: February 8, 2023, February 8, 2024 and February 8, 2025.

SEC source: 0000899243-22-005690 · doc4.xml · nonDerivative · entry 1

Fisher David · CIK 0001315224 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 516,319

F1 · shares: This transaction reflects a grant of restricted stock units that shall vest in substantially equal one-fourth increments on each of the following dates as long as grantee serves as an employee of the Issuer or an affiliate thereof through the applicable vesting date: February 8, 2023, February 8, 2024, February 8, 2025 and February 8, 2026.

SEC source: 0000899243-22-005685 · doc4.xml · derivative · entry 2

Cunningham Steven E · CIK 0001575452 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 236,597

Underlying: Common stock, par value $0.00001 per share · 10,298 shares

Expires 2029-02-08

F2 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.

F3 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.

F4 · derivative.exercise_date: The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: February 8, 2023, February 8, 2024 and February 8, 2025.

SEC source: 0000899243-22-005685 · doc4.xml · nonDerivative · entry 1

Cunningham Steven E · CIK 0001575452 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 219,577

F1 · shares: This transaction reflects a grant of restricted stock units that shall vest in substantially equal one-fourth increments on each of the following dates as long as grantee serves as an employee of the Issuer or an affiliate thereof through the applicable vesting date: February 8, 2023, February 8, 2024, February 8, 2025 and February 8, 2026.

SEC source: 0000899243-22-005683 · doc4.xml · nonDerivative · entry 1

Lee James Joseph · CIK 0001834433 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,554

F1 · shares: This transaction reflects a grant of restricted stock units that shall vest in substantially equal one-fourth increments on each of the following dates as long as grantee serves as an employee of the Issuer or an affiliate thereof through the applicable vesting date: February 8, 2023, February 8, 2024, February 8, 2025 and February 8, 2026.

SEC source: 0000899243-22-005671 · doc4.xml · derivative · entry 2

Rahilly Sean · CIK 0001621195 · General Counsel and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 120,487

Underlying: Common stock, par value $0.00001 per share · 3,506 shares

Expires 2029-02-08

F2 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.

F3 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.

F4 · derivative.exercise_date: The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: February 8, 2023, February 8, 2024 and February 8, 2025.

SEC source: 0000899243-22-005671 · doc4.xml · nonDerivative · entry 1

Rahilly Sean · CIK 0001621195 · General Counsel and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,441

F1 · shares: This transaction reflects a grant of restricted stock units that shall vest in substantially equal one-fourth increments on each of the following dates as long as grantee serves as an employee of the Issuer or an affiliate thereof through the applicable vesting date: February 8, 2023, February 8, 2024, February 8, 2025 and February 8, 2026.

SEC source: 0000899243-22-007758 · doc4a.xml · derivative · entry 1

Fisher David · CIK 0001315224 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,191,328

Underlying: Common stock, par value $0.00001 per share · 39,347 shares

Expires 2029-02-08

F1 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.

F2 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.

F3 · shares: The original Form 4, filed February 10, 2022, is being amended by this Form 4 Amendment solely to correct an administrative error, which misreported the grant of options on February 8, 2022 as a grant of 34,991 when the correct reported grant of options should have 39,347 shares. As a result of the administrative error, the total number of derivative securities beneficially owned following the transaction should be reported as 1,191,328 instead of the previously reported 1,186,972.

F4 · derivative.exercise_date: The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: February 8, 2023, February 8, 2024 and February 8, 2025.

F3 · derivative.underlying_shares: The original Form 4, filed February 10, 2022, is being amended by this Form 4 Amendment solely to correct an administrative error, which misreported the grant of options on February 8, 2022 as a grant of 34,991 when the correct reported grant of options should have 39,347 shares. As a result of the administrative error, the total number of derivative securities beneficially owned following the transaction should be reported as 1,191,328 instead of the previously reported 1,186,972.

F3 · balance_after: The original Form 4, filed February 10, 2022, is being amended by this Form 4 Amendment solely to correct an administrative error, which misreported the grant of options on February 8, 2022 as a grant of 34,991 when the correct reported grant of options should have 39,347 shares. As a result of the administrative error, the total number of derivative securities beneficially owned following the transaction should be reported as 1,191,328 instead of the previously reported 1,186,972.

SEC source: 0000899243-22-007751 · doc4a.xml · derivative · entry 1

Chartier Kirk · CIK 0001483333 · Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 234,564

Underlying: Common stock, par value $0.00001 per share · 8,102 shares

Expires 2029-02-08

F1 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.

F2 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.

F3 · shares: The original Form 4, filed February 10, 2022, is being amended by this Form 4 Amendment solely to correct an administrative error, which misreported the grant of options on February 8, 2022 as a grant of 7,205 when the correct reported grant of options should have 8,102 shares. As a result of the administrative error, the total number of derivative securities beneficially owned following the transaction should be reported as 234,564 instead of the previously reported 233,667.

F4 · derivative.exercise_date: The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: February 8, 2023, February 8, 2024 and February 8, 2025.

F3 · derivative.underlying_shares: The original Form 4, filed February 10, 2022, is being amended by this Form 4 Amendment solely to correct an administrative error, which misreported the grant of options on February 8, 2022 as a grant of 7,205 when the correct reported grant of options should have 8,102 shares. As a result of the administrative error, the total number of derivative securities beneficially owned following the transaction should be reported as 234,564 instead of the previously reported 233,667.

F3 · balance_after: The original Form 4, filed February 10, 2022, is being amended by this Form 4 Amendment solely to correct an administrative error, which misreported the grant of options on February 8, 2022 as a grant of 7,205 when the correct reported grant of options should have 8,102 shares. As a result of the administrative error, the total number of derivative securities beneficially owned following the transaction should be reported as 234,564 instead of the previously reported 233,667.

SEC source: 0000899243-22-007757 · doc4a.xml · derivative · entry 1

Cunningham Steven E · CIK 0001575452 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 237,879

Underlying: Common stock, par value $0.00001 per share · 11,580 shares

Expires 2029-02-08

F1 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.

F2 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.

F3 · shares: The original Form 4, filed February 10, 2022, is being amended by this Form 4 Amendment solely to correct an administrative error, which misreported the grant of options on February 8, 2022 as a grant of 10,298 when the correct reported grant of options should have 11,580 shares. As a result of the administrative error, the total number of derivative securities beneficially owned following the transaction should be reported as 237,879 instead of the previously reported 236,597.

F4 · derivative.exercise_date: The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: February 8, 2023, February 8, 2024 and February 8, 2025.

F3 · derivative.underlying_shares: The original Form 4, filed February 10, 2022, is being amended by this Form 4 Amendment solely to correct an administrative error, which misreported the grant of options on February 8, 2022 as a grant of 10,298 when the correct reported grant of options should have 11,580 shares. As a result of the administrative error, the total number of derivative securities beneficially owned following the transaction should be reported as 237,879 instead of the previously reported 236,597.

F3 · balance_after: The original Form 4, filed February 10, 2022, is being amended by this Form 4 Amendment solely to correct an administrative error, which misreported the grant of options on February 8, 2022 as a grant of 10,298 when the correct reported grant of options should have 11,580 shares. As a result of the administrative error, the total number of derivative securities beneficially owned following the transaction should be reported as 237,879 instead of the previously reported 236,597.

SEC source: 0000899243-22-007749 · doc4a.xml · derivative · entry 1

Rahilly Sean · CIK 0001621195 · General Counsel and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 120,924

Underlying: Common stock, par value $0.00001 per share · 3,943 shares

Expires 2029-02-08

F1 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.

F2 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.

F3 · shares: The original Form 4, filed February 10, 2022, is being amended by this Form 4 Amendment solely to correct an administrative error, which misreported the grant of options on February 8, 2022 as a grant of 3,506 when the correct reported grant of options should have 3,943 shares. As a result of the administrative error, the total number of derivative securities beneficially owned following the transaction should be reported as 120,924 instead of the previously reported 120,487.

F4 · derivative.exercise_date: The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: February 8, 2023, February 8, 2024 and February 8, 2025.

F3 · derivative.underlying_shares: The original Form 4, filed February 10, 2022, is being amended by this Form 4 Amendment solely to correct an administrative error, which misreported the grant of options on February 8, 2022 as a grant of 3,506 when the correct reported grant of options should have 3,943 shares. As a result of the administrative error, the total number of derivative securities beneficially owned following the transaction should be reported as 120,924 instead of the previously reported 120,487.

F3 · balance_after: The original Form 4, filed February 10, 2022, is being amended by this Form 4 Amendment solely to correct an administrative error, which misreported the grant of options on February 8, 2022 as a grant of 3,506 when the correct reported grant of options should have 3,943 shares. As a result of the administrative error, the total number of derivative securities beneficially owned following the transaction should be reported as 120,924 instead of the previously reported 120,487.

SEC source: 0000899243-22-004986 · doc4.xml · nonDerivative · entry 2

Fisher David · CIK 0001315224 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 440,443

F1 · kind: The sale reported in this Form 4 was effected pursuant to Mr. Fisher's Rule 10b5-1 trading plan.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.30 to $40.57, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The sales were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

SEC source: 0000899243-22-004986 · doc4.xml · nonDerivative · entry 1

Fisher David · CIK 0001315224 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 444,837

F1 · kind: The sale reported in this Form 4 was effected pursuant to Mr. Fisher's Rule 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.05 to $39.08, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The sales were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

SEC source: 0000899243-22-002284 · doc4.xml · nonDerivative · entry 1

Rahilly Sean · CIK 0001621195 · General Counsel and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,837

F1 · kind: The sale reported in this Form 4 was effected pursuant to Mr. Rahilly's Rule 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.70 to $44.43, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The sales were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

SEC source: 0000899243-22-001875 · doc4.xml · nonDerivative · entry 1

Fisher David · CIK 0001315224 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 452,608

F1 · kind: The sale reported in this Form 4 was effected pursuant to Mr. Fisher's Rule 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.02 to $42.86, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The sales were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

SEC source: 0000899243-21-048729 · doc4.xml · nonDerivative · entry 1

Rahilly Sean · CIK 0001621195 · General Counsel and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,267

F1 · kind: The sale reported in this Form 4 was effected pursuant to Mr. Rahilly's Rule 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.45 to $38.80, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The sales were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

SEC source: 0000899243-21-046745 · doc4.xml · nonDerivative · entry 1

Fisher David · CIK 0001315224 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 468,111

F1 · kind: The sale reported in this Form 4 was effected pursuant to Mr. Fisher's Rule 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.99 to $38.09, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The sales were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

SEC source: 0000899243-21-045034 · doc4.xml · nonDerivative · entry 1

Rahilly Sean · CIK 0001621195 · General Counsel and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 78,697

F1 · kind: The sale reported in this Form 4 was effected pursuant to Mr. Rahilly's Rule 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.06 to $42.86, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The sales were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

SEC source: 0000950170-23-072979 · ownership.xml · nonDerivative · entry 1

Fisher David · CIK 0001315224 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 443,660

F1 · kind: The original Form 4, filed November 15, 2021, is being amended by this Form 4 Amendment solely to correct an administrative error, which omitted the sale of 32,428 shares at an average sale price of $42.1443. As a result of the administrative error, the total number of securities beneficially owned following the transaction should be reported as 443,660.

F2 · kind: The sale reported in this Form 4 was effected pursuant to Mr. Fisher's Rule 10b5-1 trading plan.

F3 · price: The price reported in Column 4 "Price" is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.65 to $42.77, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

SEC source: 0000899243-21-044692 · doc4.xml · derivative · entry 1

Fisher David · CIK 0001315224 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,066,339

Underlying: Common stock, par value $0.00001 per share · 59,143 shares

Expires 2021-12-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.

F2 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.

F3 · derivative.exercise_price: The price reported in Column 2 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.70 to $41.08, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F4 · derivative.exercise_date: The options vested in substantially equal one-third increments on each of the following dates as long as grantee served as an employee of Issuer or an affiliate thereof through the applicable vesting date: December 13, 2015, December 13, 2016 and December 13, 2017.

SEC source: 0000899243-21-043909 · doc4.xml · derivative · entry 1

Fisher David · CIK 0001315224 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,125,482

Underlying: Common stock, par value $0.00001 per share · 50,000 shares

Expires 2021-12-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.

F2 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.

F3 · derivative.exercise_price: The price reported in Column 2 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.75 to $39.93, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F4 · derivative.exercise_date: The options vested in substantially equal one-third increments on each of the following dates as long as grantee served as an employee of Issuer or an affiliate thereof through the applicable vesting date: December 13, 2015, December 13, 2016 and December 13, 2017.

SEC source: 0000899243-22-009532 · doc4.xml · nonDerivative · entry 1

Lee James Joseph · CIK 0001834433 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,194

F1 · shares: This transaction represents the withholding by Enova International, Inc. ("Issuer") of Issuer's shares to pay taxes in connections with the vesting of restricted stock units on the Transaction Date. The timing and amount of the transaction were determined by the terms of the applicable restricted stock and were not within the control of the Reporting Person.

F2 · balance_after: Includes timed-based restricted stock units previously granted to the Reporting Person.

SEC source: 0000899243-22-009553 · doc4.xml · derivative · entry 2

Chartier Kirk · CIK 0001483333 · Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 226,462

Underlying: Common stock, par value $0.00001 per share · 9,410 shares

Expires 2028-11-04

F1 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.

F2 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.

F4 · derivative.exercise_date: The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: February 4, 2023, February 4, 2024 and February 4, 2025.

SEC source: 0000899243-22-009545 · doc4.xml · derivative · entry 3

Fisher David · CIK 0001315224 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,261,124

Underlying: Common stock, par value $0.00001 per share · 43,176 shares

Expires 2028-11-04

F1 · security: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.

F2 · security: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.

F6 · derivative.exercise_date: The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: February 4, 2023, February 4, 2024 and February 4, 2025.